Albumin Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Albumin market size was valued at USD 5356.7 million in 2022 and is forecast to a readjusted size of USD 8224.2 million by 2029 with a CAGR of 6.3% during review period.

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.

This report is a detailed and comprehensive analysis for global Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Albumin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Albumin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   CSL
   Grifols
   Shire (Baxalta)
   Octapharma
   Hualan Bio
   CBPO
   RAAS
   Kedrion
   Merck
   LFB Group
   Albumedix
   Thermo Fisher Scientific

   Human Serum Albumin
   Bovine Serum Albumin
   Recombinant Albumin

   Therapeutics
   Vaccine Ingredient
   Culture Medium Ingredient
   Others

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Albumin Market in 2025?

The strength of the Albumin Market in 2025 lies in its widespread use across various medical conditions, including liver diseases, burns, and trauma. Its critical role in therapeutic treatments, combined with a growing aging population, ensures a steady demand.

What are the weaknesses of the Albumin Market in 2025?

One weakness is the high cost of production and purification, which can limit market accessibility in developing regions. Additionally, the reliance on blood plasma as a source can be problematic due to potential shortages or ethical concerns related to donor plasma.

What opportunities exist in the Albumin Market in 2025?

Opportunities include the expanding application of albumin in drug delivery systems and vaccines, especially DNA vaccines. With increasing healthcare spending and technological advancements in manufacturing processes, the market has room for growth in emerging markets.

What are the threats to the Albumin Market in 2025?

Threats include regulatory challenges, such as stringent safety standards, and the potential rise of alternative therapies like synthetic albumin. The market also faces competition from biosimilars and recombinant products, which could reduce reliance on human-derived albumin.

What political factors impact the Albumin Market in 2025?

Political factors like government regulations regarding blood plasma sourcing, healthcare policies, and funding for medical treatments can heavily influence the Albumin Market. Stricter regulations on safety and production standards can increase operational costs and affect supply chains.

How do economic factors affect the Albumin Market in 2025?

Economic factors, such as healthcare expenditure and GDP growth, directly influence the demand for albumin in healthcare systems. Economic instability or recession in certain regions can result in reduced healthcare budgets, potentially affecting market growth, particularly in low-income countries.

What social factors influence the Albumin Market in 2025?

Social factors like an aging population, rising awareness about chronic conditions, and the increasing prevalence of liver and kidney diseases drive demand for albumin. Additionally, there is a growing emphasis on advanced therapies, which further fuels the market for albumin-based products.

What technological factors affect the Albumin Market in 2025?

Technological advancements in recombinant albumin production, biosynthesis, and drug delivery systems provide new avenues for the market. These innovations can reduce production costs, improve product quality, and enhance the therapeutic applications of albumin.

What environmental factors impact the Albumin Market in 2025?

Environmental concerns around the sourcing of blood plasma and waste generated during the production process may lead to increased scrutiny from regulatory bodies. Additionally, sustainability practices in production processes are becoming more important, with companies focusing on eco-friendly solutions.

What legal factors influence the Albumin Market in 2025?

Legal factors such as intellectual property rights, patent laws for recombinant albumin products, and regulations on plasma collection and usage play a significant role in shaping the market. Compliance with global standards and the approval process for new albumin-based treatments are key considerations for companies.

Who are the suppliers in the Albumin Market in 2025?

Suppliers in the Albumin Market include plasma collection centers, biopharmaceutical companies, and manufacturers of recombinant albumin. These suppliers provide the raw materials, technologies, and manufacturing expertise required for albumin production.

What are the inputs to the Albumin Market in 2025?

The inputs to the Albumin Market include human plasma, recombinant DNA technology, specialized production equipment, and regulatory compliance for safety and quality standards. Raw materials and skilled labor also contribute to the production process.

What are the processes involved in the Albumin Market in 2025?

The key processes in the Albumin Market include plasma collection, albumin extraction, purification, quality control, packaging, and distribution. The production process also involves compliance with regulatory guidelines and ensuring product efficacy and safety.

What are the outputs of the Albumin Market in 2025?

The primary outputs of the Albumin Market are therapeutic albumin products used for treating conditions like liver disease, burns, trauma, and hypoalbuminemia. The market also produces recombinant albumin for research and development purposes, as well as drug delivery systems.

Who are the customers in the Albumin Market in 2025?

Customers in the Albumin Market include hospitals, healthcare providers, pharmaceutical companies, research institutions, and patients requiring albumin-based therapies. The market also serves the growing needs of the biotech and pharmaceutical industries for advanced drug delivery systems.

What is the threat of new entrants in the Albumin Market in 2025?

The threat of new entrants is relatively low due to high barriers to entry, such as the significant capital investment required for production facilities, regulatory compliance, and expertise in plasma collection and purification. Established players dominate the market, making it difficult for new companies to compete.

What is the bargaining power of suppliers in the Albumin Market in 2025?

Suppliers have moderate bargaining power, as the market relies heavily on a limited number of plasma collection centers and advanced biomanufacturing technologies. However, the growing trend of recombinant albumin production offers some alternatives, slightly reducing supplier power over time.

What is the bargaining power of buyers in the Albumin Market in 2025?

The bargaining power of buyers is moderate. While there is a steady demand for albumin-based therapies, the high cost and critical nature of the product give suppliers leverage. However, buyers such as hospitals and pharmaceutical companies can negotiate based on bulk orders and long-term contracts.

What is the threat of substitute products in the Albumin Market in 2025?

The threat of substitutes is moderate, as alternative treatments such as synthetic albumin and recombinant albumin products are emerging. However, these substitutes still face challenges in replicating the full range of therapeutic benefits of human-derived albumin, limiting their immediate competitive threat.

What is the intensity of competitive rivalry in the Albumin Market in 2025?

The intensity of competitive rivalry is high, with several well-established companies dominating the market. These companies compete on factors such as product quality, production efficiency, pricing, and regulatory compliance. As the market continues to grow, competition will intensify further with the advent of new technologies and biosimilars.

What are the key upstream factors influencing the Albumin Market in 2025?

Key upstream factors include the availability and cost of plasma collection, advancements in recombinant DNA technology for albumin production, and the sourcing of raw materials. Regulatory requirements surrounding the collection, processing, and safety of plasma also significantly impact upstream activities.

How do suppliers affect the upstream dynamics in the Albumin Market in 2025?

Suppliers of raw plasma, bioreactor technology, and purification equipment play a crucial role in the upstream dynamics. Limited suppliers of high-quality plasma can influence pricing, while technological suppliers affect production efficiency and the development of alternative albumin sources like recombinant products.

What role does research and development (R&D) play in the upstream segment of the Albumin Market in 2025?

R&D is crucial in the upstream segment, driving innovation in recombinant albumin production and improving the efficiency of purification processes. R&D also enables the development of synthetic alternatives and helps address challenges related to supply and cost, thereby influencing the market's upstream growth.

How do regulatory and legal factors impact upstream activities in the Albumin Market in 2025?

Regulatory and legal factors, such as plasma donation laws, safety protocols, and quality control standards, significantly impact upstream activities. These regulations ensure the safety and ethical sourcing of plasma, but they can also increase operational costs and complicate the supply chain.

What are the supply chain challenges in the upstream segment of the Albumin Market in 2025?

Challenges in the upstream supply chain include maintaining a consistent and ethical supply of plasma, addressing logistical issues related to global distribution, and managing the complexities of regulatory compliance. Additionally, the potential for plasma shortages due to increasing demand can strain the supply chain.

What are the key midstream factors influencing the Albumin Market in 2025?

Key midstream factors include the refining and purification processes of albumin, which are central to ensuring high-quality therapeutic products. The effectiveness and efficiency of these processes, along with cost management, impact the market dynamics. Additionally, technological advancements in manufacturing play a crucial role in enhancing production scalability.

How does manufacturing affect the midstream dynamics in the Albumin Market in 2025?

Manufacturing processes, such as plasma fractionation and recombinant protein production, are vital in the midstream segment. The ability to scale production while maintaining product quality directly influences the market. Any improvements in technology or process efficiency can lower costs and improve overall market competitiveness.

What role does quality control play in the midstream segment of the Albumin Market in 2025?

Quality control is critical in the midstream segment to ensure that albumin meets safety standards and regulatory requirements. Rigorous testing for purity, efficacy, and sterility is necessary for patient safety and market acceptance. Quality assurance processes help build trust with healthcare providers and patients.

What are the logistical challenges in the midstream segment of the Albumin Market in 2025?

Logistical challenges include maintaining the cold chain during the storage and transportation of albumin products, especially given their sensitivity to temperature. Efficient distribution channels are needed to ensure timely and safe delivery of albumin products to healthcare providers, particularly in remote or underserved regions.

How do partnerships and collaborations impact the midstream activities in the Albumin Market in 2025?

Partnerships between biopharmaceutical companies, technology providers, and contract manufacturing organizations (CMOs) play a significant role in enhancing midstream capabilities. These collaborations facilitate access to specialized technologies, improve production efficiency, and expand distribution networks, enabling companies to meet growing demand.

What are the key downstream factors influencing the Albumin Market in 2025?

Key downstream factors include the distribution and sale of albumin-based products to hospitals, clinics, and pharmacies. The demand for albumin therapies in critical care, particularly for liver disease and burns, plays a crucial role in shaping downstream activities. Additionally, market access and regulatory approvals are essential for reaching end-users.

How does distribution affect the downstream dynamics in the Albumin Market in 2025?

Distribution is vital in ensuring albumin reaches healthcare providers in a timely manner. Efficient logistics, including cold chain management and global distribution networks, are essential for maintaining product efficacy. Any disruption in distribution can lead to stock shortages or delays in treatment, affecting patient care.

What role does pricing and reimbursement play in the downstream segment of the Albumin Market in 2025?

Pricing and reimbursement policies are significant in the downstream segment, as albumin-based therapies are expensive. The level of reimbursement from insurance providers and healthcare systems can influence the adoption of albumin products, especially in regions with limited healthcare budgets. Competitive pricing strategies are crucial for market penetration.

How do healthcare providers and pharmaceutical companies impact the downstream activities in the Albumin Market in 2025?

Healthcare providers and pharmaceutical companies play a central role in the downstream segment by prescribing albumin-based treatments and driving demand. Their partnerships with manufacturers also influence product distribution, marketing strategies, and the overall accessibility of albumin therapies to patients.

What are the customer engagement challenges in the downstream segment of the Albumin Market in 2025?

Customer engagement challenges in the downstream segment include educating healthcare providers on the latest albumin-based treatments and addressing concerns over the high cost of therapies. Additionally, reaching underserved populations in emerging markets and ensuring consistent supply chains to meet demand are significant hurdles.

Chapter 1, to describe Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin, with price, sales, revenue and global market share of Albumin from 2018 to 2023.
Chapter 3, the Albumin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Albumin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin.
Chapter 14 and 15, to describe Albumin sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Albumin
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Albumin Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Human Serum Albumin
       1.3.3 Bovine Serum Albumin
       1.3.4 Recombinant Albumin
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Albumin Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Therapeutics
       1.4.3 Vaccine Ingredient
       1.4.4 Culture Medium Ingredient
       1.4.5 Others
   1.5 Global Albumin Market Size & Forecast
       1.5.1 Global Albumin Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Albumin Sales Quantity (2018-2029)
       1.5.3 Global Albumin Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 CSL
       2.1.1 CSL Details
       2.1.2 CSL Major Business
       2.1.3 CSL Albumin Product and Services
       2.1.4 CSL Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 CSL Recent Developments/Updates
   2.2 Grifols
       2.2.1 Grifols Details
       2.2.2 Grifols Major Business
       2.2.3 Grifols Albumin Product and Services
       2.2.4 Grifols Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Grifols Recent Developments/Updates
   2.3 Shire (Baxalta)
       2.3.1 Shire (Baxalta) Details
       2.3.2 Shire (Baxalta) Major Business
       2.3.3 Shire (Baxalta) Albumin Product and Services
       2.3.4 Shire (Baxalta) Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Shire (Baxalta) Recent Developments/Updates
   2.4 Octapharma
       2.4.1 Octapharma Details
       2.4.2 Octapharma Major Business
       2.4.3 Octapharma Albumin Product and Services
       2.4.4 Octapharma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Octapharma Recent Developments/Updates
   2.5 Hualan Bio
       2.5.1 Hualan Bio Details
       2.5.2 Hualan Bio Major Business
       2.5.3 Hualan Bio Albumin Product and Services
       2.5.4 Hualan Bio Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Hualan Bio Recent Developments/Updates
   2.6 CBPO
       2.6.1 CBPO Details
       2.6.2 CBPO Major Business
       2.6.3 CBPO Albumin Product and Services
       2.6.4 CBPO Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 CBPO Recent Developments/Updates
   2.7 RAAS
       2.7.1 RAAS Details
       2.7.2 RAAS Major Business
       2.7.3 RAAS Albumin Product and Services
       2.7.4 RAAS Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 RAAS Recent Developments/Updates
   2.8 Kedrion
       2.8.1 Kedrion Details
       2.8.2 Kedrion Major Business
       2.8.3 Kedrion Albumin Product and Services
       2.8.4 Kedrion Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Kedrion Recent Developments/Updates
   2.9 Merck
       2.9.1 Merck Details
       2.9.2 Merck Major Business
       2.9.3 Merck Albumin Product and Services
       2.9.4 Merck Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Merck Recent Developments/Updates
   2.10 LFB Group
       2.10.1 LFB Group Details
       2.10.2 LFB Group Major Business
       2.10.3 LFB Group Albumin Product and Services
       2.10.4 LFB Group Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 LFB Group Recent Developments/Updates
   2.11 Albumedix
       2.11.1 Albumedix Details
       2.11.2 Albumedix Major Business
       2.11.3 Albumedix Albumin Product and Services
       2.11.4 Albumedix Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Albumedix Recent Developments/Updates
   2.12 Thermo Fisher Scientific
       2.12.1 Thermo Fisher Scientific Details
       2.12.2 Thermo Fisher Scientific Major Business
       2.12.3 Thermo Fisher Scientific Albumin Product and Services
       2.12.4 Thermo Fisher Scientific Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Thermo Fisher Scientific Recent Developments/Updates

3 Competitive Environment: Albumin by Manufacturer

   3.1 Global Albumin Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Albumin Revenue by Manufacturer (2018-2023)
   3.3 Global Albumin Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Albumin Manufacturer Market Share in 2022
       3.4.2 Top 6 Albumin Manufacturer Market Share in 2022
   3.5 Albumin Market: Overall Company Footprint Analysis
       3.5.1 Albumin Market: Region Footprint
       3.5.2 Albumin Market: Company Product Type Footprint
       3.5.3 Albumin Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Albumin Market Size by Region
       4.1.1 Global Albumin Sales Quantity by Region (2018-2029)
       4.1.2 Global Albumin Consumption Value by Region (2018-2029)
       4.1.3 Global Albumin Average Price by Region (2018-2029)
   4.2 North America Albumin Consumption Value (2018-2029)
   4.3 Europe Albumin Consumption Value (2018-2029)
   4.4 Asia-Pacific Albumin Consumption Value (2018-2029)
   4.5 South America Albumin Consumption Value (2018-2029)
   4.6 Middle East and Africa Albumin Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Albumin Sales Quantity by Type (2018-2029)
   5.2 Global Albumin Consumption Value by Type (2018-2029)
   5.3 Global Albumin Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Albumin Sales Quantity by Application (2018-2029)
   6.2 Global Albumin Consumption Value by Application (2018-2029)
   6.3 Global Albumin Average Price by Application (2018-2029)

7 North America

   7.1 North America Albumin Sales Quantity by Type (2018-2029)
   7.2 North America Albumin Sales Quantity by Application (2018-2029)
   7.3 North America Albumin Market Size by Country
       7.3.1 North America Albumin Sales Quantity by Country (2018-2029)
       7.3.2 North America Albumin Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Albumin Sales Quantity by Type (2018-2029)
   8.2 Europe Albumin Sales Quantity by Application (2018-2029)
   8.3 Europe Albumin Market Size by Country
       8.3.1 Europe Albumin Sales Quantity by Country (2018-2029)
       8.3.2 Europe Albumin Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Albumin Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Albumin Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Albumin Market Size by Region
       9.3.1 Asia-Pacific Albumin Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Albumin Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Albumin Sales Quantity by Type (2018-2029)
   10.2 South America Albumin Sales Quantity by Application (2018-2029)
   10.3 South America Albumin Market Size by Country
       10.3.1 South America Albumin Sales Quantity by Country (2018-2029)
       10.3.2 South America Albumin Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Albumin Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Albumin Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Albumin Market Size by Country
       11.3.1 Middle East & Africa Albumin Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Albumin Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Albumin Market Drivers
   12.2 Albumin Market Restraints
   12.3 Albumin Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Albumin and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Albumin
   13.3 Albumin Production Process
   13.4 Albumin Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Albumin Typical Distributors
   14.3 Albumin Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Albumin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Albumin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. CSL Basic Information, Manufacturing Base and Competitors
   Table 4. CSL Major Business
   Table 5. CSL Albumin Product and Services
   Table 6. CSL Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. CSL Recent Developments/Updates
   Table 8. Grifols Basic Information, Manufacturing Base and Competitors
   Table 9. Grifols Major Business
   Table 10. Grifols Albumin Product and Services
   Table 11. Grifols Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Grifols Recent Developments/Updates
   Table 13. Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
   Table 14. Shire (Baxalta) Major Business
   Table 15. Shire (Baxalta) Albumin Product and Services
   Table 16. Shire (Baxalta) Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Shire (Baxalta) Recent Developments/Updates
   Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
   Table 19. Octapharma Major Business
   Table 20. Octapharma Albumin Product and Services
   Table 21. Octapharma Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Octapharma Recent Developments/Updates
   Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
   Table 24. Hualan Bio Major Business
   Table 25. Hualan Bio Albumin Product and Services
   Table 26. Hualan Bio Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Hualan Bio Recent Developments/Updates
   Table 28. CBPO Basic Information, Manufacturing Base and Competitors
   Table 29. CBPO Major Business
   Table 30. CBPO Albumin Product and Services
   Table 31. CBPO Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. CBPO Recent Developments/Updates
   Table 33. RAAS Basic Information, Manufacturing Base and Competitors
   Table 34. RAAS Major Business
   Table 35. RAAS Albumin Product and Services
   Table 36. RAAS Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. RAAS Recent Developments/Updates
   Table 38. Kedrion Basic Information, Manufacturing Base and Competitors
   Table 39. Kedrion Major Business
   Table 40. Kedrion Albumin Product and Services
   Table 41. Kedrion Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Kedrion Recent Developments/Updates
   Table 43. Merck Basic Information, Manufacturing Base and Competitors
   Table 44. Merck Major Business
   Table 45. Merck Albumin Product and Services
   Table 46. Merck Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Merck Recent Developments/Updates
   Table 48. LFB Group Basic Information, Manufacturing Base and Competitors
   Table 49. LFB Group Major Business
   Table 50. LFB Group Albumin Product and Services
   Table 51. LFB Group Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. LFB Group Recent Developments/Updates
   Table 53. Albumedix Basic Information, Manufacturing Base and Competitors
   Table 54. Albumedix Major Business
   Table 55. Albumedix Albumin Product and Services
   Table 56. Albumedix Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Albumedix Recent Developments/Updates
   Table 58. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
   Table 59. Thermo Fisher Scientific Major Business
   Table 60. Thermo Fisher Scientific Albumin Product and Services
   Table 61. Thermo Fisher Scientific Albumin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Thermo Fisher Scientific Recent Developments/Updates
   Table 63. Global Albumin Sales Quantity by Manufacturer (2018-2023) & (MT)
   Table 64. Global Albumin Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 65. Global Albumin Average Price by Manufacturer (2018-2023) & (USD/MT)
   Table 66. Market Position of Manufacturers in Albumin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 67. Head Office and Albumin Production Site of Key Manufacturer
   Table 68. Albumin Market: Company Product Type Footprint
   Table 69. Albumin Market: Company Product Application Footprint
   Table 70. Albumin New Market Entrants and Barriers to Market Entry
   Table 71. Albumin Mergers, Acquisition, Agreements, and Collaborations
   Table 72. Global Albumin Sales Quantity by Region (2018-2023) & (MT)
   Table 73. Global Albumin Sales Quantity by Region (2024-2029) & (MT)
   Table 74. Global Albumin Consumption Value by Region (2018-2023) & (USD Million)
   Table 75. Global Albumin Consumption Value by Region (2024-2029) & (USD Million)
   Table 76. Global Albumin Average Price by Region (2018-2023) & (USD/MT)
   Table 77. Global Albumin Average Price by Region (2024-2029) & (USD/MT)
   Table 78. Global Albumin Sales Quantity by Type (2018-2023) & (MT)
   Table 79. Global Albumin Sales Quantity by Type (2024-2029) & (MT)
   Table 80. Global Albumin Consumption Value by Type (2018-2023) & (USD Million)
   Table 81. Global Albumin Consumption Value by Type (2024-2029) & (USD Million)
   Table 82. Global Albumin Average Price by Type (2018-2023) & (USD/MT)
   Table 83. Global Albumin Average Price by Type (2024-2029) & (USD/MT)
   Table 84. Global Albumin Sales Quantity by Application (2018-2023) & (MT)
   Table 85. Global Albumin Sales Quantity by Application (2024-2029) & (MT)
   Table 86. Global Albumin Consumption Value by Application (2018-2023) & (USD Million)
   Table 87. Global Albumin Consumption Value by Application (2024-2029) & (USD Million)
   Table 88. Global Albumin Average Price by Application (2018-2023) & (USD/MT)
   Table 89. Global Albumin Average Price by Application (2024-2029) & (USD/MT)
   Table 90. North America Albumin Sales Quantity by Type (2018-2023) & (MT)
   Table 91. North America Albumin Sales Quantity by Type (2024-2029) & (MT)
   Table 92. North America Albumin Sales Quantity by Application (2018-2023) & (MT)
   Table 93. North America Albumin Sales Quantity by Application (2024-2029) & (MT)
   Table 94. North America Albumin Sales Quantity by Country (2018-2023) & (MT)
   Table 95. North America Albumin Sales Quantity by Country (2024-2029) & (MT)
   Table 96. North America Albumin Consumption Value by Country (2018-2023) & (USD Million)
   Table 97. North America Albumin Consumption Value by Country (2024-2029) & (USD Million)
   Table 98. Europe Albumin Sales Quantity by Type (2018-2023) & (MT)
   Table 99. Europe Albumin Sales Quantity by Type (2024-2029) & (MT)
   Table 100. Europe Albumin Sales Quantity by Application (2018-2023) & (MT)
   Table 101. Europe Albumin Sales Quantity by Application (2024-2029) & (MT)
   Table 102. Europe Albumin Sales Quantity by Country (2018-2023) & (MT)
   Table 103. Europe Albumin Sales Quantity by Country (2024-2029) & (MT)
   Table 104. Europe Albumin Consumption Value by Country (2018-2023) & (USD Million)
   Table 105. Europe Albumin Consumption Value by Country (2024-2029) & (USD Million)
   Table 106. Asia-Pacific Albumin Sales Quantity by Type (2018-2023) & (MT)
   Table 107. Asia-Pacific Albumin Sales Quantity by Type (2024-2029) & (MT)
   Table 108. Asia-Pacific Albumin Sales Quantity by Application (2018-2023) & (MT)
   Table 109. Asia-Pacific Albumin Sales Quantity by Application (2024-2029) & (MT)
   Table 110. Asia-Pacific Albumin Sales Quantity by Region (2018-2023) & (MT)
   Table 111. Asia-Pacific Albumin Sales Quantity by Region (2024-2029) & (MT)
   Table 112. Asia-Pacific Albumin Consumption Value by Region (2018-2023) & (USD Million)
   Table 113. Asia-Pacific Albumin Consumption Value by Region (2024-2029) & (USD Million)
   Table 114. South America Albumin Sales Quantity by Type (2018-2023) & (MT)
   Table 115. South America Albumin Sales Quantity by Type (2024-2029) & (MT)
   Table 116. South America Albumin Sales Quantity by Application (2018-2023) & (MT)
   Table 117. South America Albumin Sales Quantity by Application (2024-2029) & (MT)
   Table 118. South America Albumin Sales Quantity by Country (2018-2023) & (MT)
   Table 119. South America Albumin Sales Quantity by Country (2024-2029) & (MT)
   Table 120. South America Albumin Consumption Value by Country (2018-2023) & (USD Million)
   Table 121. South America Albumin Consumption Value by Country (2024-2029) & (USD Million)
   Table 122. Middle East & Africa Albumin Sales Quantity by Type (2018-2023) & (MT)
   Table 123. Middle East & Africa Albumin Sales Quantity by Type (2024-2029) & (MT)
   Table 124. Middle East & Africa Albumin Sales Quantity by Application (2018-2023) & (MT)
   Table 125. Middle East & Africa Albumin Sales Quantity by Application (2024-2029) & (MT)
   Table 126. Middle East & Africa Albumin Sales Quantity by Region (2018-2023) & (MT)
   Table 127. Middle East & Africa Albumin Sales Quantity by Region (2024-2029) & (MT)
   Table 128. Middle East & Africa Albumin Consumption Value by Region (2018-2023) & (USD Million)
   Table 129. Middle East & Africa Albumin Consumption Value by Region (2024-2029) & (USD Million)
   Table 130. Albumin Raw Material
   Table 131. Key Manufacturers of Albumin Raw Materials
   Table 132. Albumin Typical Distributors
   Table 133. Albumin Typical Customers

List of Figures

   Figure 1. Albumin Picture
   Figure 2. Global Albumin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Albumin Consumption Value Market Share by Type in 2022
   Figure 4. Human Serum Albumin Examples
   Figure 5. Bovine Serum Albumin Examples
   Figure 6. Recombinant Albumin Examples
   Figure 7. Global Albumin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Albumin Consumption Value Market Share by Application in 2022
   Figure 9. Therapeutics Examples
   Figure 10. Vaccine Ingredient Examples
   Figure 11. Culture Medium Ingredient Examples
   Figure 12. Others Examples
   Figure 13. Global Albumin Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 14. Global Albumin Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 15. Global Albumin Sales Quantity (2018-2029) & (MT)
   Figure 16. Global Albumin Average Price (2018-2029) & (USD/MT)
   Figure 17. Global Albumin Sales Quantity Market Share by Manufacturer in 2022
   Figure 18. Global Albumin Consumption Value Market Share by Manufacturer in 2022
   Figure 19. Producer Shipments of Albumin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 20. Top 3 Albumin Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Top 6 Albumin Manufacturer (Consumption Value) Market Share in 2022
   Figure 22. Global Albumin Sales Quantity Market Share by Region (2018-2029)
   Figure 23. Global Albumin Consumption Value Market Share by Region (2018-2029)
   Figure 24. North America Albumin Consumption Value (2018-2029) & (USD Million)
   Figure 25. Europe Albumin Consumption Value (2018-2029) & (USD Million)
   Figure 26. Asia-Pacific Albumin Consumption Value (2018-2029) & (USD Million)
   Figure 27. South America Albumin Consumption Value (2018-2029) & (USD Million)
   Figure 28. Middle East & Africa Albumin Consumption Value (2018-2029) & (USD Million)
   Figure 29. Global Albumin Sales Quantity Market Share by Type (2018-2029)
   Figure 30. Global Albumin Consumption Value Market Share by Type (2018-2029)
   Figure 31. Global Albumin Average Price by Type (2018-2029) & (USD/MT)
   Figure 32. Global Albumin Sales Quantity Market Share by Application (2018-2029)
   Figure 33. Global Albumin Consumption Value Market Share by Application (2018-2029)
   Figure 34. Global Albumin Average Price by Application (2018-2029) & (USD/MT)
   Figure 35. North America Albumin Sales Quantity Market Share by Type (2018-2029)
   Figure 36. North America Albumin Sales Quantity Market Share by Application (2018-2029)
   Figure 37. North America Albumin Sales Quantity Market Share by Country (2018-2029)
   Figure 38. North America Albumin Consumption Value Market Share by Country (2018-2029)
   Figure 39. United States Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Canada Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Mexico Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Europe Albumin Sales Quantity Market Share by Type (2018-2029)
   Figure 43. Europe Albumin Sales Quantity Market Share by Application (2018-2029)
   Figure 44. Europe Albumin Sales Quantity Market Share by Country (2018-2029)
   Figure 45. Europe Albumin Consumption Value Market Share by Country (2018-2029)
   Figure 46. Germany Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. France Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. United Kingdom Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Russia Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Italy Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Asia-Pacific Albumin Sales Quantity Market Share by Type (2018-2029)
   Figure 52. Asia-Pacific Albumin Sales Quantity Market Share by Application (2018-2029)
   Figure 53. Asia-Pacific Albumin Sales Quantity Market Share by Region (2018-2029)
   Figure 54. Asia-Pacific Albumin Consumption Value Market Share by Region (2018-2029)
   Figure 55. China Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Japan Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Korea Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. India Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Southeast Asia Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. Australia Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. South America Albumin Sales Quantity Market Share by Type (2018-2029)
   Figure 62. South America Albumin Sales Quantity Market Share by Application (2018-2029)
   Figure 63. South America Albumin Sales Quantity Market Share by Country (2018-2029)
   Figure 64. South America Albumin Consumption Value Market Share by Country (2018-2029)
   Figure 65. Brazil Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Argentina Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 67. Middle East & Africa Albumin Sales Quantity Market Share by Type (2018-2029)
   Figure 68. Middle East & Africa Albumin Sales Quantity Market Share by Application (2018-2029)
   Figure 69. Middle East & Africa Albumin Sales Quantity Market Share by Region (2018-2029)
   Figure 70. Middle East & Africa Albumin Consumption Value Market Share by Region (2018-2029)
   Figure 71. Turkey Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Egypt Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Saudi Arabia Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. South Africa Albumin Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. Albumin Market Drivers
   Figure 76. Albumin Market Restraints
   Figure 77. Albumin Market Trends
   Figure 78. Porters Five Forces Analysis
   Figure 79. Manufacturing Cost Structure Analysis of Albumin in 2022
   Figure 80. Manufacturing Process Analysis of Albumin
   Figure 81. Albumin Industrial Chain
   Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 83. Direct Channel Pros & Cons
   Figure 84. Indirect Channel Pros & Cons
   Figure 85. Methodology
   Figure 86. Research Process and Data Source